Rivastigmin Patch Sandoz 5

Rivastigmin Patch Sandoz 5 is a medicine authorised by Swissmedic under authorisation number 63164. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 11 June 2013 and the authorisation is valid without a time limit. ATC code N06DA03 places the medicine in the group Psychoanaleptics.

  • Dispensing category B
  • Authorisation number 63164
  • ATC N06DA03
  • Synthetic medicines
Authorisation data
Authorisation number63164
NameRivastigmin Patch Sandoz 5
Full nameRivastigmin Patch Sandoz 5, Transdermales Pflaster
Authorisation holderSandoz Pharmaceuticals AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeN06DA03
First authorisation11 June 2013
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Rivastigmin Patch Sandoz 5, Transdermales PflasterB11 June 2013
2Rivastigmin Patch Sandoz 10, Transdermales PflasterB11 June 2013
3Rivastigmin Patch Sandoz 15, Transdermales PflasterB13 March 2014

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
1130PflasterN06DA0301.99.0.B
1230PflasterN06DA0301.99.0.B
1360PflasterN06DA0301.99.0.B
1430PflasterN06DA0301.99.0.B
1560PflasterN06DA0301.99.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Rivastigmin Patch Sandoz 5 authorised in Switzerland?

Yes. Rivastigmin Patch Sandoz 5 is authorised by Swissmedic under authorisation number 63164, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Rivastigmin Patch Sandoz 5 have?

Rivastigmin Patch Sandoz 5 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Rivastigmin Patch Sandoz 5?

The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com